Pierre Casellas

12.4k total citations · 3 hit papers
123 papers, 10.3k citations indexed

About

Pierre Casellas is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, Pierre Casellas has authored 123 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 42 papers in Cellular and Molecular Neuroscience and 37 papers in Immunology. Recurrent topics in Pierre Casellas's work include Toxin Mechanisms and Immunotoxins (31 papers), Cannabis and Cannabinoid Research (30 papers) and Receptor Mechanisms and Signaling (27 papers). Pierre Casellas is often cited by papers focused on Toxin Mechanisms and Immunotoxins (31 papers), Cannabis and Cannabinoid Research (30 papers) and Receptor Mechanisms and Signaling (27 papers). Pierre Casellas collaborates with scholars based in France, United States and United Kingdom. Pierre Casellas's co-authors include Monsif Bouaboula, Gérard Le Fur, David Shire, Sylvaine Galiègue, Pierre Carayon, Jean Marchand, D. Dussossoy, Dominique Carrière, Jean‐Marie Derocq and Bernard Calandra and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Pierre Casellas

121 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations

1995 1.4k citations D. Dussossoy, Pierre Carayon et al. European Journal of Biochemistry profile →
lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses

1993 758 citations A Minty, Pascale Chalon et al. Nature profile →
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor

1998 593 citations M Rinaldi-Carmona, Francis Barth et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pierre Casellas France	50	5.0k	3.7k	3.1k	2.1k	1.2k	123	10.3k
Pascual Ferrara France	53	2.2k 0.4×	4.8k 1.3×	7.1k 2.3×	2.7k 1.3×	486 0.4×	165	14.7k
David Shire France	33	4.9k 1.0×	3.3k 0.9×	1.9k 0.6×	1.0k 0.5×	1.1k 0.9×	73	7.8k
David Baker United Kingdom	64	3.3k 0.7×	2.4k 0.6×	4.8k 1.6×	3.1k 1.5×	680 0.6×	296	15.4k
Alain P. Gobert France	58	1.1k 0.2×	4.4k 1.2×	4.0k 1.3×	1.1k 0.5×	809 0.7×	164	9.4k
Teresa Iuvone Italy	41	3.2k 0.6×	1.2k 0.3×	1.2k 0.4×	660 0.3×	521 0.4×	87	5.8k
Thierry Pedrazzini Switzerland	52	1.4k 0.3×	3.4k 0.9×	5.4k 1.8×	1.5k 0.7×	765 0.6×	137	12.8k
Fred Van Leuven Belgium	61	1.8k 0.4×	2.7k 0.7×	7.0k 2.3×	1.1k 0.5×	335 0.3×	206	14.2k
Giuseppe Esposito Italy	44	3.0k 0.6×	1.2k 0.3×	1.6k 0.5×	370 0.2×	556 0.5×	161	6.3k
S. H. Ferreira Brazil	57	2.6k 0.5×	2.4k 0.6×	3.2k 1.0×	1.6k 0.8×	113 0.1×	132	11.8k
Shuji Hinuma Japan	42	2.8k 0.6×	3.4k 0.9×	2.9k 1.0×	924 0.4×	316 0.3×	89	10.1k

Countries citing papers authored by Pierre Casellas

Since Specialization

Citations

This map shows the geographic impact of Pierre Casellas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Casellas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Casellas more than expected).

Fields of papers citing papers by Pierre Casellas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Casellas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Casellas. The network helps show where Pierre Casellas may publish in the future.

Co-authorship network of co-authors of Pierre Casellas

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Casellas. A scholar is included among the top collaborators of Pierre Casellas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Casellas. Pierre Casellas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abood, Mary E., Christian C. Felder, Peter J. Greasley, et al.. (2025). Cannabinoid receptors in GtoPdb v.2025.1. IUPHAR/BPS Guide to Pharmacology CITE. 2025(1).

Abood, Mary E., S P H Alexander, Francis Barth, et al.. (2023). Cannabinoid receptors in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE. 2023(1). 3 indexed citations

Abood, Mary E., S P H Alexander, Francis Barth, et al.. (2019). Cannabinoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019(4). 12 indexed citations

Ruggeri, Bruce, Ted L. Underiner, Diane E. Gingrich, et al.. (2007). CEP-11981: A potent TIE-2/Pan-VEGF-R inhibitor with broad kinase inhibitory activity exhibits significant antitumor and antiangiogenic efficacy in preclinical tumor models. Molecular Cancer Therapeutics. 6. 2 indexed citations

Gross, Antoine, Monsif Bouaboula, Pierre Casellas, Jean‐Pierre Liautard, & Jacques Dornand. (2003). Subversion and Utilization of the Host Cell Cyclic Adenosine 5′-Monophosphate/Protein Kinase A Pathway by Brucella During Macrophage Infection. The Journal of Immunology. 170(11). 5607–5614. 41 indexed citations

Ouafik, L’Houcine, Françoise Boudouresque, Olivier Chinot, et al.. (2002). Neutralization of Adrenomedullin Inhibits the Growth of Human Glioblastoma Cell Lines in Vitro and Suppresses Tumor Xenograft Growth in Vivo. American Journal Of Pathology. 160(4). 1279–1292. 108 indexed citations

Bribes, Estelle, Pierre Casellas, Hubert Vidal, D. Dussossoy, & Daniel Casellas. (2002). Peripheral Benzodiazepine Receptor Mapping in Rat Kidney. Effects of Angiotensin II-Induced Hypertension. Journal of the American Society of Nephrology. 13(1). 1–9. 24 indexed citations

Seth, Pankaj, Malliga E. Ganapathy, Simon J. Conway, et al.. (2001). Expression pattern of the type 1 sigma receptor in the brain and identity of critical anionic amino acid residues in the ligand-binding domain of the receptor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1540(1). 59–67. 74 indexed citations

Derocq, Jean‐Marie, Monsif Bouaboula, J Marchand, et al.. (1998). The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor‐independent pathway in hematopoietic cell lines. FEBS Letters. 425(3). 419–425. 69 indexed citations

10.

Bouaboula, Monsif, Laura Milligan, Xavier Canat, et al.. (1997). A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1. Journal of Biological Chemistry. 272(35). 22330–22339. 396 indexed citations

11.

Dussossoy, D., et al.. (1996). Development of a monoclonal antibody to immuno-cytochemical analysis of the cellular localization of the peripheral benzodiazepine receptor. Cytometry. 24(1). 39–48. 31 indexed citations

12.

Derocq, Jean‐Marie, Michel Ségui, J Marchand, G. Le Fur, & Pierre Casellas. (1995). Cannabinoids enhance human B‐cell growth at low nanomolar concentrations. FEBS Letters. 369(2-3). 177–182. 151 indexed citations

13.

Carayon, P, et al.. (1995). The sigma ligand SR 31747 prevents the development of acute graft-versus-host disease in mice by blocking IFN-γ and GM-CSF mRNA expression. International Journal of Immunopharmacology. 17(9). 753–761. 25 indexed citations

14.

Gal, C. Serradeil‐Le, B. Bourrié, Danielle Raufaste, et al.. (1994). Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on swiss 3T3 cells. Biochemical Pharmacology. 47(4). 633–641. 26 indexed citations

15.

Casellas, Pierre, Bernard Bourrié, Xavier Canat, et al.. (1994). Immunopharmacological profile of SR 31747: In vitro and in vivo studies on humoral and cellular responses. Journal of Neuroimmunology. 52(2). 193–203. 44 indexed citations

16.

Minty, A, Pascale Chalon, Jean‐Marie Derocq, et al.. (1993). lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature. 362(6417). 248–250. 758 indexed citations breakdown →

17.

Dornand, Jacques, Monsif Bouaboula, Arnaud Dupuy d’Angeac, et al.. (1992). Contrasting effects of the protein kinase C inhibitor staurosporine on the interleukin‐1 and phorbol ester activation pathways in the EL4–6.1 thymoma cell line. Journal of Cellular Physiology. 151(1). 71–80. 23 indexed citations

18.

Casellas, Pierre, et al.. (1990). Internalization of the cytotoxic molecules of T101 F(ab′)₂— (ricin‐A‐chain) immunotoxin into human T‐leukemic cells. European Journal of Biochemistry. 192(2). 469–473. 12 indexed citations

19.

Hertler, Andrew, David M. Schlossman, Michael J. Borowitz, et al.. (1989). An anti‐CD5 immunotoxin for chronic lymphocytic leukemia: Enhancement of cytotoxicity with human serum albumin‐monensin. International Journal of Cancer. 43(2). 215–219. 54 indexed citations

20.

Derocq, Jean‐Marie, et al.. (1988). Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.. The Journal of Immunology. 141(8). 2837–2843. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact